Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Journal of Mammary Gland Biology and Neoplasia|October 1, 1996
Therapeutic implications of the TGF-beta systemB A ArrickOncogene|February 15, 2001
Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant formsM Lu, B A ArrickCancer Research|October 1, 1984
Glutathione metabolism as a determinant of therapeutic efficacy: a reviewB A Arrick, C F NathanCancer Research|January 15, 1990
Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiolB A Arrick, M Korc, R DerynckThe Journal of Experimental Medicine|March 1, 1981
Inhibition of glutathione synthesis as a chemotherapeutic strategy for trypanosomiasisB A Arrick, O W Griffith, A CeramiMolecular and Cellular Biology|January 1, 1994
Enhanced translational efficiency of a novel transforming growth factor beta 3 mRNA in human breast cancer cellsB A Arrick, R L Grendell, L A GriffinThe Journal of Clinical Investigation|February 1, 1983
Inhibition of glutathione synthesis augments lysis of murine tumor cells by sulfhydryl-reactive antineoplasticsB A Arrick, C F Nathan, Z A CohnThe Journal of Clinical Investigation|August 1, 1985
Hydrogen peroxide from cellular metabolism of cystine. A requirement for lysis of murine tumor cells by vernolepin, a glutathione-depleting antineoplasticB A Arrick, W Griffo, Z Cohn, et al.Cancer Research|October 15, 1996
Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cellsM Lu, S D Conzen, C N Cole, et al.Molecular and Cellular Biology|September 1, 1991
Inhibition of translation of transforming growth factor-beta 3 mRNA by its 5' untranslated regionB A Arrick, A L Lee, R L Grendell, et al.Pageof 2